Vanguard Capital Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
GJL
Vanguard Capital Management's CLB Position: Q3 2026 in Review
Vanguard Capital Management reduced its Core Laboratories (CLB) stake by 0.78% in Q3 2026, selling an estimated $143K and leaving 1,578,165 shares worth $15.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2534.
Vanguard Capital Management first reported a position in CLB in Q1 2026 and has held it in 3 quarters since. The position peaked at $27.2M in Q1 2026. 180 funds tracked by Wall St. Rank hold CLB as of Q3 2026.
- Vanguard Capital Management held 1,578,165 shares of Core Laboratories worth $15.3M as of Q3 2026.
- Vanguard Capital Management sold 12,356 Core Laboratories shares in Q3 2026, an estimated $143K.
- Core Laboratories made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2534 holding.
- Vanguard Capital Management first reported a position in Core Laboratories in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Core Laboratories position peaked at $27.2M in Q1 2026.
- 180 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.